Financial Daily from THE HINDU group of publications
Sunday, Feb 06, 2005

News
Features
Stocks
Port Info
Archives
Google

Group Sites

Industry & Economy - Pharmaceuticals


`Give priority to drug affordability'

Our Bureau

New Delhi , Feb. 5

"PATIENTS come first. Patents next," said Mr William F. Haddad, Chairman and CEO of Biogenerics Inc and the United States Research and Development Corporation, who was here recently.

Championing the cause of drug affordability, Mr Haddad — popularly known as the father of the US generics industry — said that on January 1, when the products patent regime came into effect, "a perfect storm of political intrigue, corporate greed and a lack of political will congealed into a reality that will systematically deny not only India but two-thirds of the world's population access to life saving essential medicines".

Pandemics and diseases that can be controlled by new medicines will be denied to India and other developing and under-developed nations because competition is no longer possible.

"India and China, under national laws that produced these medicines without infringing patents, were the principal suppliers of essential medicines to poor nations who are now confused about where they will be able to obtain these medicines from," he added.

He also squashed the claims made by the Government and other organisations around the world that over 90 per cent of the medicines on the WHO list are off patent.

"Further under TRIPS, most of the sections of the Ordinance are not required by the WTO. The multinational pharmaceutical corporations are convincing countries around the world, including India, that this TRIPS Plus regulation is required," Mr Haddad said.

Pointing out that HIV/AIDS is a growing epidemic, Mr Haddad said that the availability of cheap anti-retroviral drugs is crucial for the patient.

Almost every AIDS organisation in the world has written to the Prime Minister, Dr Manmohan Singh, to stand tall and resist the pressures to change its policies, he added.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page


Stories in this Section
Marketing can be done without a patent: Madras HC


Larger firms post sizeable growth in profits — Results reflect fresh capacities going on stream
Double taxation pact between India, Philippines modified
`EU-India business summit to open new vistas for trade ties with Finland'
`Adopt constructive approach to facilitate Doha trade talks'
`Foreign trade share poised to double by 2009'
Psychotropic drugs — Finance Ministry asked to go slow on raids
`Give priority to drug affordability'
Pharma SSIs in a quandary over excise duty on MRP
5,000 MW of fresh power capacity planned in 2 years
Govt plans dedicated steel capacities for exports
VAT will bring down prices: Shome
`Time right for textile players to grow fast'
Boycott Australian wool, Maneka Gandhi urges Indian cos
Labour Minister meets PM on EPF rate issue
Education cess not applicable for imports under advance licences
Contributions to The Hindu Relief Fund
Action plan for tourism revival in tsunami-hit nations


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line